While the Trump administration is pushing to accelerate clinical AI adoption, SCAI has emphasized that physicians must guide how the technology is implemented and governed.

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short. 

Multiple cardiology societies responded to an HHS request for public feedback by outlining some of the current barriers to wider AI adoption. "It is essential that any policy frameworks must reaffirm that clinicians—not algorithms—remain at the center of patient care," ACC President Christopher Kramer, MD, said. 

The group's hope is that these new funds will help address the rising rates of PAD and CLTI throughout the United States.

The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

In fact, researchers wrote, TAVR and SAVR were linked to comparable long-term outcomes for heart patients who have previously been exposed to mediastinal radiation. 

The new guidance, the first of its kind, focuses on the importance of making a prompt diagnosis and providing care as quickly as possible. While some PE patients with mild cases can be discharged early, others may require an immediate catheter-based intervention or surgery.

SCAI has shared a new call to action as an observance of American Heart Month. The group is asking Congress to pass new pieces of legislation that could improve care for PAD patients and get important medical devices in the hands of interventional cardiologists.